Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

475 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor-derived microvesicles: the metastasomes.
Ghasemi R, Grassadonia A, Tinari N, Piccolo E, Natoli C, Tomao F, Iacobelli S. Ghasemi R, et al. Among authors: iacobelli s. Med Hypotheses. 2013 Jan;80(1):75-82. doi: 10.1016/j.mehy.2012.10.011. Epub 2012 Nov 21. Med Hypotheses. 2013. PMID: 23177570
90K (Mac-2 BP) and galectins in tumor progression and metastasis.
Grassadonia A, Tinari N, Iurisci I, Piccolo E, Cumashi A, Innominato P, D'Egidio M, Natoli C, Piantelli M, Iacobelli S. Grassadonia A, et al. Among authors: iacobelli s. Glycoconj J. 2002;19(7-9):551-6. doi: 10.1023/B:GLYC.0000014085.00706.d4. Glycoconj J. 2002. PMID: 14758079 Review.
Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer.
Zilli M, Grassadonia A, Tinari N, Di Giacobbe A, Gildetti S, Giampietro J, Natoli C, Iacobelli S; Consorzio Interuniversitario Nazionale per la Bio-Oncologia (CINBO). Zilli M, et al. Among authors: iacobelli s. Biochim Biophys Acta. 2009 Jan;1795(1):62-81. doi: 10.1016/j.bbcan.2008.08.003. Epub 2008 Aug 29. Biochim Biophys Acta. 2009. PMID: 18804516 Review.
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies.
Tinari N, Lattanzio R, Querzoli P, Natoli C, Grassadonia A, Alberti S, Hubalek M, Reimer D, Nenci I, Bruzzi P, Piantelli M, Iacobelli S; Consorzio Interuniversitario Nazionale per la Bio-Oncologia (CINBO). Tinari N, et al. Among authors: iacobelli s. Int J Cancer. 2009 Jan 15;124(2):333-8. doi: 10.1002/ijc.23970. Int J Cancer. 2009. PMID: 18942707
Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody.
Traini S, Piccolo E, Tinari N, Rossi C, La Sorda R, Spinella F, Bagnato A, Lattanzio R, D'Egidio M, Di Risio A, Tomao F, Grassadonia A, Piantelli M, Natoli C, Iacobelli S. Traini S, et al. Among authors: iacobelli s. Mol Cancer Ther. 2014 Apr;13(4):916-25. doi: 10.1158/1535-7163.MCT-12-1117. Epub 2014 Feb 19. Mol Cancer Ther. 2014. PMID: 24552775
LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis.
Piccolo E, Tinari N, Semeraro D, Traini S, Fichera I, Cumashi A, La Sorda R, Spinella F, Bagnato A, Lattanzio R, D'Egidio M, Di Risio A, Stampolidis P, Piantelli M, Natoli C, Ullrich A, Iacobelli S. Piccolo E, et al. Among authors: iacobelli s. J Mol Med (Berl). 2013 Jan;91(1):83-94. doi: 10.1007/s00109-012-0936-6. Epub 2012 Aug 5. J Mol Med (Berl). 2013. PMID: 22864925
EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo.
Sala G, Rapposelli IG, Ghasemi R, Piccolo E, Traini S, Capone E, Rossi C, Pelliccia A, Di Risio A, D'Egidio M, Tinari N, Muraro R, Iacobelli S; Consorzio Interuniversitario Nazionale per la Bio-Oncologia (CINBO). Sala G, et al. Among authors: iacobelli s. Transl Oncol. 2013 Dec 1;6(6):676-84. doi: 10.1593/tlo.13475. eCollection 2013 Dec 1. Transl Oncol. 2013. PMID: 24466370 Free PMC article.
475 results